Advertisements

Baclofen Mylan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Baclofen Mylan

This section defines the identity, classification, and general function of Baclofen Mylan, providing essential facts and expert verification.

Property Description
Active Ingredient Baclofen (INN)
Form Oral Tablet
Pharmacological Class Skeletal Muscle Relaxant, Antispastic Agent
General Purpose Reduction of muscle stiffness and involuntary spasms (spasticity)
Origin Synthetic compound (GABA derivative)

Baclofen: Definition and Core Classification

Baclofen Mylan is a prescription-only, single-ingredient medication classified as a skeletal muscle relaxant and a specific type of antispastic agent. This classification places it within the therapeutic group of medicines used to manage conditions characterized by involuntary and persistent muscle stiffness or tightness, primarily in adult patients.

The drug's active component, Baclofen (INN), is a synthetic derivative structurally related to gamma-aminobutyric acid (GABA), a key inhibitory chemical messenger in the central nervous system. Baclofen is considered a centrally acting agent because its effects primarily target nerve pathways in the spinal cord, modulating the neurological signals that directly control muscle tone. Its use in managing severe spasticity is clinically utilized in the field of neurology.


Composition, Form, and General Purpose

The medication contains Baclofen as its sole active ingredient and is typically presented as an oral dosage form, most commonly a tablet. As a product manufactured under the Mylan brand, it is a generic formulation containing the same active ingredient as the original innovator product. The usual route of administration is oral, enabling systemic absorption to reach its central site of action.

Baclofen’s function serves the general therapeutic purpose of reducing spasticity by dampening the overactive nervous reflexes responsible for excessive muscle rigidity. Baclofen is authorized for treating muscle spasm due to conditions such as multiple sclerosis or spinal cord disease. This application supports the drug's role in helping to restore greater flexibility and ease movement by promoting muscle relaxation.

Regulatory References

  1. skeletal muscle relaxant
  2. MedlinePlus
Advertisements

What side effects are possible with Baclofen Mylan?

Possible Side Effects and Safety Information

The safety profile of Baclofen is formally documented by regulatory authorities, classifying possible effects by frequency and the body system affected. These effects primarily relate to its central action as a muscle relaxant.


Frequency-Classified Adverse Reactions

The most commonly reported adverse reactions are often related to the central nervous system (CNS), and their occurrence is categorized as follows in official labeling:

Classification Examples of Documented Effects
Very Common (ge 1/10) Somnolence (Drowsiness), Sedation
Common (ge 1/100 to < 1/10) Dizziness, Headache, Nausea, Fatigue, Muscle Weakness, Hypotension, Insomnia
Uncommon to Rare Rash, Dry Mouth, Respiratory Depression, Hallucinations

Safety Patterns and Special Considerations

Adverse effects are grouped by System-Organ Class, with the most prominent being Nervous System Disorders (e.g., sedation, ataxia) and Gastrointestinal Disorders (e.g., nausea, vomiting). Many CNS effects are more frequently observed at the start of treatment and during dose increases.

The regulatory safety profile highlights Serious Adverse Reactions, including Respiratory Depression (a rare event) and the risk of Seizures and Hallucinations associated with the abrupt discontinuation of therapy.

Population-specific safety considerations are noted for certain groups. Older adults may show increased sensitivity to the CNS effects and muscle weakness. Additionally, due to the primary route of elimination, patients with renal impairment require specific caution to prevent drug accumulation and potential toxicity. The primary safety restriction is the mandatory requirement for gradual withdrawal to avoid the severe withdrawal phenomena documented in the official safety records.

Advertisements

Overdose and Emergency Response

Baclofen Overdose and When to Seek Help

Official regulatory information describes a Baclofen overdose as a medical emergency requiring immediate attention due to its potential to cause severe central nervous system (CNS) and respiratory depression. Toxicity has been reported with high oral doses (e.g., 200 mg or more in adults) and in patients with impaired kidney function, even at low doses.

Documented Overdose Manifestations

Symptoms are primarily neurological and respiratory, and may progress rapidly:

System Symptoms
Neurological Somnolence, confusion, disorientation, hallucinations, profound depression of consciousness, or coma. Seizures and absent reflexes (areflexia) may also occur.
Respiratory Respiratory depression, which can lead to acute respiratory failure requiring mechanical ventilation.
Cardiovascular Hypotension (low blood pressure) and bradycardia (slow heart rate).

Required Emergency Actions

Immediate medical help must be sought for any suspected overdose. Contact a Poison Control Center or emergency services right away. The management of Baclofen overdose is entirely symptomatic and supportive, as no specific antidote is available. Hospital-based care will focus on measures to maintain respiration, blood pressure, and body temperature. Airway management and assisted ventilation may be necessary due to the risk of respiratory failure. Patients with known kidney impairment are at heightened risk and require close monitoring for signs of toxicity.

The overall overdose profile mandates that individuals seek urgent medical evaluation regardless of how they feel, due to the high risk of delayed but serious CNS and respiratory complications.

Advertisements

Therapeutic Uses of Baclofen Mylan

Baclofen Mylan is applied across domains where additional symptomatic support is needed for managing symptoms related to increased neurological or muscular activity. As a skeletal muscle relaxant, the medication is commonly used across conditions presenting with acute episodes characterized by periods of heightened symptoms.

It provides support that helps ease the overall symptom burden. This contributes to improved comfort during periods of heightened symptoms and supports the patient during episodes of heightened discomfort. It is considered relevant for easing symptoms that interfere with daily comfort, relevant in contexts involving heightened systemic burden.

The medicine assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations. This is particularly relevant when supportive symptom management is appropriate in clinical settings that involve acute or unstable symptom patterns. It provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Symptoms related to heightened physiological activity

Regulatory References

  1. Baclofen: MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Baclofen Mylan

The official regulatory documentation for oral baclofen defines eligibility based on age, hypersensitivity, organ function, and pre-existing conditions.


Eligibility Domain Regulatory Statement
Contraindication (Absolute) Patients with a known hypersensitivity to baclofen or any tablet excipients are prohibited from use.
Age-Group Eligibility Approved for use in adults and adolescents ge 12 years of age. Use in children under 12 years is not established by US and Canadian regulators.
Organ Function Restriction Individuals with impaired renal function or those on dialysis must use the medicine with caution due to risk of toxicity. Severe kidney failure requires the benefit to outweigh the risk.
Special Caution Populations Older adults require a cautious dosage schedule due to increased sensitivity. Patients with a history of stroke, epilepsy, or certain psychotic disorders also require close surveillance.
Pregnancy and Lactation Use during pregnancy is conditional, permitted only if the potential benefit justifies the risk. Small amounts are excreted in human milk; nursing is generally advised only if the benefit outweighs the risk to the infant.

Regulatory documentation establishes the primary approved patient group while setting clear exclusions for hypersensitivity. Beyond absolute contraindications, use is formally restricted for those with compromised organ function, in the elderly, and in patients with specific neurological or psychiatric comorbidities, mandating caution and monitoring to align with established safety boundaries.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Baclofen Mylan as specified in government regulatory sources. The drug's interaction profile is primarily defined by additive effects on the central nervous system (CNS) and its dependence on renal clearance.


Documented Pharmacodynamic Interactions

Co-administration with Central Nervous System (CNS) Depressants, including alcohol, may result in additive CNS depressant effects such as increased sedation and drowsiness. The combination with Antihypertensive Agents carries the risk of an increased fall in blood pressure (hypotension). Additionally, officially documented interactions with Tricyclic Antidepressants may cause pronounced muscular hypotonia, and co-use with Levodopa/Carbidopa has been reported to induce symptoms such as mental confusion and agitation.


Clearance and Exposure Risks

Baclofen is largely excreted unchanged, meaning no significant CYP-mediated (metabolic) interactions are specified in regulatory sources. However, substances that reduce renal function may increase Baclofen plasma concentrations due to reduced clearance. This risk is particularly noted in patients with impaired renal function, where the effects of Baclofen may be heightened due to slower removal from the body.

Advertisements

Mechanism of Action

How Baclofen Mylan Works: Mechanism of Action

Baclofen Mylan modulates motor system signaling through interaction with specific neural receptors, primarily acting as an agonist at the Gamma-Aminobutyric Acid type B ( GABAB) receptors.

GABA-B Receptor Agonism

This interaction involves the drug binding to the GABAB receptors, which are G-protein coupled receptors located both pre- and post-synaptically. Pre-synaptic activation of these receptors decreases the influx of calcium ions, leading to a reduction in the release of excitatory neurotransmitters (such as glutamate and aspartate) within the spinal cord. Post-synaptic activation increases the efflux of potassium ions, which promotes a state of hyperpolarization of the neuronal membrane.

Spinal Polysynaptic Pathway Modulation

This dual action leads to the overall inhibition of both monosynaptic and polysynaptic reflex arcs, particularly those within the spinal cord that regulate muscle tone. The resulting physiological sequence is a net shift toward reduced neuronal excitability and decreased spontaneous depolarization of motor neurons, thereby modifying the output of hyperexcitable neural circuits.

Advertisements

Dosage and Administration Information

Baclofen Mylan is an oral medication with a highly structured regimen for proper administration, defined by established protocols. The tablets are taken via the oral route, and the procedure for starting and stopping the treatment is clearly defined.

The standard dosing protocol emphasizes gradual initiation. Treatment typically begins with a low initial dose of 5 mg three times daily (TID). The dose is not immediately increased; instead, it must be systematically titrated by an increase of 5 mg per dose every three days until the optimal procedural response is achieved. This ensures the lowest effective dose is identified, which usually falls within an adult maintenance range of 40 mg to 80 mg daily.

The total daily amount must be administered in divided doses, typically three or four times per day (TID or QID). For the proper intake of the tablets, they should be consumed with or after food. A single dose may be timed approximately one hour before specific activities, such as physiotherapy, to potentially enhance mobility.

Specific modifications to the regimen are required for certain groups; for instance, older adults and patients with renal impairment must be managed with a very cautious, low-dose schedule. A critical procedural constraint is the required gradual discontinuation. The medicine must never be stopped abruptly; the dose must be slowly reduced over a period of one to two weeks to conclude treatment.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oral Baclofen Mylan

Evidence for Use in Spasticity from Multiple Sclerosis and Spinal Cord Disease

The body of research for oral baclofen includes Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that focused on studies examining spasticity—a condition marked by persistent muscle stiffness and involuntary spasms—particularly for adults with underlying conditions like multiple sclerosis or spinal cord disease. These studies integrate findings from multiple trials.

In these trials, research examined how symptoms evolved in the observed populations. Outcomes measured focused on changes in muscle tone using standardized clinical scales, such as the Ashworth Scale, and changes in the frequency of involuntary spasms. Findings describe patterns observed in the studies where measurements related to tone and spasm activity were recorded during the short-term evaluation periods. Research also explored associated outcomes related to physical discomfort, such as pain, which was measured in some studies. These studies contribute to the broader evidence landscape by providing insight into short-term changes in muscle tightness and spasms.


Long-Term Studies and Durability of Follow-up

The majority of clinical studies that focused on the research evidence for oral baclofen were designed to research exploring short-term symptom changes—typically over periods ranging from a few days up to a few months. Follow-up durations were limited in many of the core efficacy trials.

While some studies collected data related to outcomes over defined time intervals, the research on long-term effects is not fully established. There is limited information for long-term outcomes regarding the sustained effects over periods of a year or more. Observational studies provide some context on long-term usage patterns, but they do not offer the same rigorous data on durability as randomized trials.


What Is Still Uncertain in the Research for Oral Baclofen

The current research landscape highlights several areas where knowledge is still developing or limited:

  • Outcomes reflecting daily functioning or activity level are less clear than the measurements for muscle tone. Many studies focused on objective physiological measurements, but findings were mixed when assessing the impact on functional abilities, such as mobility or the performance of activities of daily living.
  • Sample sizes were modest in many of the older, foundational studies, and evidence quality varies across studies based on their specific design and controls.
  • While evidence highlights what is known so far, research does not determine whether an individual will respond similarly to the patterns observed in the trials, as findings describe group patterns, not personal outcomes.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Baclofen Mylan (FAQ)

Q: How quickly does Baclofen Mylan start working after taking it?

Official information does not specify an exact timeframe for when the oral tablet's overall systemic effects begin. However, a single dose may sometimes be scheduled approximately one hour before activities like physical therapy to potentially aid mobility and muscle relaxation during that time.

Q: How long do the effects of Baclofen Mylan last?

The official dosing instructions recommend taking the total daily amount in divided doses, typically three or four times per day. Based on this typical dosing schedule, the effects of a single dose are expected to last several hours.

Q: Is Baclofen Mylan addictive?

Baclofen is not classified as an opioid. However, official regulatory warnings emphasize that the medicine must never be stopped suddenly, as this can lead to severe withdrawal phenomena, including hallucinations and seizures. This requirement for gradual reduction indicates a potential for physical dependence with long-term use.

Q: What is the longest time someone can usually take Baclofen Mylan?

The core clinical trials for oral baclofen typically focused on short-term changes, usually over a few days up to a few months. Official information notes that research on long-term effects is limited and not fully established, although safety patterns have been monitored in patients treated for up to one year.

Q: Is Baclofen Mylan considered an opioid?

No, Baclofen is officially classified as a skeletal muscle relaxant and an antispastic agent. It is not classified as an opioid, nor is it listed as a controlled substance by regulatory bodies like the DEA.

Q: What happens if I miss a dose of Baclofen Mylan?

If a dose is missed, official patient information suggests taking it as soon as it is remembered. However, if it is very close to the time for the next scheduled dose (e.g., within two hours), official guidance advises skipping the missed dose. Taking a double dose to make up for a forgotten one is typically advised against.

Q: Can I drive while I am taking Baclofen Mylan?

Regulatory documents caution that the medication may cause effects like drowsiness, dizziness, or vision problems. Due to this potential, caution is required, and patients may need to avoid activities like driving or operating machinery until they understand the drug’s effects.

Q: Does Baclofen Mylan affect mental clarity or focus?

The official safety profile notes several effects related to mental state, including confusion and insomnia as documented neuropsychiatric adverse reactions. As drowsiness is a common side effect, official documents note the importance of caution with activities requiring high mental alertness.

Q: Is Baclofen Mylan used for nerve pain too?

The official indications for oral baclofen are for managing the signs and symptoms of spasticity, which is persistent muscle stiffness associated with conditions like multiple sclerosis or spinal cord disease. Its authorized use is not for general nerve pain or neuropathic pain.

Q: Are there any specific groups of people who should not take Baclofen Mylan?

Yes, Baclofen is contraindicated in patients with a known hypersensitivity to the drug or its ingredients. This means its use is formally advised against under these conditions. Regulatory documents also note that special caution is required for older adults, patients with impaired kidney function, those with a history of stroke, epilepsy, or certain psychotic conditions.

Q: Does Baclofen Mylan cause weight changes?

Regulatory documents list both weight gain and, less commonly, weight loss as possible adverse reactions. However, these effects are not categorized among the most frequently reported side effects.

Q: Does Baclofen Mylan cause confusion?

Yes, official regulatory information indicates that confusion is a potential adverse reaction. It is listed as a neuropsychiatric effect, reported in 1% to 11% of patients in clinical studies.

Q: Is Baclofen Mylan safe for long-term use?

Official information indicates that the research on long-term effects is not fully established, as most core clinical studies focused on short-term changes over several months. While safety patterns have been monitored over longer periods (up to one year), evidence regarding the drug’s sustained effects and safety profile beyond that period is limited.

Q: What are the major contraindications for Baclofen Mylan?

The only major absolute exclusion established in regulatory documents is hypersensitivity (an allergic reaction) to baclofen or any of the inactive ingredients. Use of the medicine is contraindicated under this condition.

Q: Is Baclofen Mylan effective for all types of muscle stiffness?

No, Baclofen is officially indicated to manage the signs and symptoms of spasticity, a specific type of severe muscle stiffness that results from conditions affecting the spinal cord or brain, such as multiple sclerosis. It is not indicated for general or common skeletal muscle spasms from other disorders.

Q: Can I take Baclofen Mylan if I am breastfeeding?

Regulatory documents state that small amounts of the medicine are known to be excreted into human milk. Official advice is conditional, permitting nursing only if the potential benefit to the mother is determined to outweigh the risk of harm to the infant.

Q: How should I expect to feel after starting Baclofen Mylan?

When first starting the medicine, the most common effects reported include drowsiness, sedation, dizziness, and headache. Official information notes that these central nervous system effects are usually most noticeable at the beginning of the treatment and during dosage adjustments.

Q: Are allergic reactions to Baclofen Mylan common?

The single absolute exclusion in the drug's safety profile is known hypersensitivity to baclofen. While official information lists skin rash and itching as possible adverse reactions, they are not classified among the most common effects reported by patients.

Advertisements

How should Baclofen Mylan be stored and disposed of?

Storage and Disposal of Baclofen Tablets

Baclofen tablets must be stored according to specific regulatory requirements to ensure product integrity and safety.


Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (mathbf20 to 25 C or mathbf68 to 77 F).
Protection Keep in a well-closed container and protect from light and moisture.
Child Safety Store the medication out of the sight and reach of children. Child-resistant closures are required where mandated.

Disposal Instructions

Official labeling generally indicates no special requirements for the disposal of unused Baclofen tablets. Expired or unused medication should be discarded in accordance with local regulations and guidelines for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Baclofen Mylan found in:

A-Z Index: